Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | 44,382 | reported | 01 May 2026 | tx 64+170,373−70,288 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 5,000 | 52.27 USD | 10b5-1 |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 600 | 227.45 USD | 10b5-1 |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 932 | 228.75 USD | 10b5-1 |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 98 | 229.71 USD | 10b5-1 |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 370 | 230.87 USD | 10b5-1 |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 780 | 232.04 USD | 10b5-1 |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 1,420 | 232.92 USD | 10b5-1 |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 800 | 234.02 USD | 10b5-1 |
| 01 May 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 5,000 | 0.00 USD | 10b5-1deriv |
| 02 Mar 2026 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 4,513 | 0.00 USD | |
| 02 Mar 2026 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 21,525 | 0.00 USD | deriv |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 100 | 197.70 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 100 | 199.01 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 207 | 199.96 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 93 | 200.62 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 1,142 | 208.87 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 200 | 204.17 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 460 | 205.18 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 340 | 206.37 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 612 | 207.01 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 1,446 | 208.12 USD | |
| 04 Mar 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 5,000 | 52.27 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 300 | 201.70 USD | |
| 04 Mar 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 5,000 | 0.00 USD | deriv |
| 15 Feb 2026 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 593 | 183.83 USD |